# Omalizumab (Genetical Recombination) S.C. Injection 300mg Pen (ゾレア皮下注３００ｍｇペン)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2290400G5027). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2290400G5027
- **Product name (Japanese):** ゾレア皮下注３００ｍｇペン
- **English title:** Omalizumab (Genetical Recombination) S.C. Injection 300mg Pen
- **Active ingredient:** オマリズマブ（遺伝子組換え）
- **Active ingredient (INN):** Omalizumab (Genetical Recombination)
- **Strength / unit:** ３００ｍｇ２ｍＬ１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 22 Respiratory agents (呼吸器官用薬) › 229 Other respiratory agents (その他の呼吸器官用薬)
- **Manufacturer:** Novartis Pharma (ノバルティス ファーマ)
- **NHI price (reference only):** JPY 39329 per ３００ｍｇ２ｍＬ１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2290400G5027
- **JSON:** https://www.nifujipharma.com/api/drugs/2290400G5027

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Omalizumab%20(Genetical%20Recombination)%20S.C.%20Injection%20300mg%20Pen%20(%E3%82%BE%E3%83%AC%E3%82%A2%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%93%EF%BC%90%EF%BC%90%EF%BD%8D%EF%BD%87%E3%83%9A%E3%83%B3)%20%2F%20YJ%202290400G5027#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Omalizumab (Genetical Recombination)

- [Omalizumab (Genetical Recombination) for S.C. Injection 150mg (ゾレア皮下注用１５０ｍｇ)](https://www.nifujipharma.com/drugs/2290400D1033) — １５０ｍｇ１瓶, Novartis Pharma
- [Omalizumab (Genetical Recombination) S.C. Injection 75mg Syringe (ゾレア皮下注７５ｍｇシリンジ)](https://www.nifujipharma.com/drugs/2290400G1021) — ７５ｍｇ０．５ｍＬ１筒, Novartis Pharma
- [Omalizumab (Genetical Recombination) S.C. Injection 150mg Syringe (ゾレア皮下注１５０ｍｇシリンジ)](https://www.nifujipharma.com/drugs/2290400G2028) — １５０ｍｇ１ｍＬ１筒, Novartis Pharma
- [Omalizumab (Genetical Recombination) S.C. Injection 75mg Pen (ゾレア皮下注７５ｍｇペン)](https://www.nifujipharma.com/drugs/2290400G3024) — ７５ｍｇ０．５ｍＬ１キット, Novartis Pharma
- [Omalizumab (Genetical Recombination) S.C. Injection 150mg Pen (ゾレア皮下注１５０ｍｇペン)](https://www.nifujipharma.com/drugs/2290400G4020) — １５０ｍｇ１ｍＬ１キット, Novartis Pharma